Position in JBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,495,694
+$2,297,191 QoQ
Shares Held
427,349
-16.6% QoQ
Ownership
0.672%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#35
of 153 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JBIO Over Time
Shares Held
Position Value (USD)
Derivatives in JBIO
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. JBIO ranks #20 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in JBIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,495,694 | 427,349 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,198,503 | 512,349 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,629,000 | 300,000 | Shares | Sole | 2026-02-18 | |
| 2024-09-30 AVTE | — | 367,965 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 AVTE | — | 367,965 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 AVTE | — | 1,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 AVTE | — | 367,965 | Shares | Sole | 2024-05-17 | |
| 2023-03-31 AVTE | — | 195,146 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 AVTE | — | 127,921 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 AVTE | — | 200,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||